Table 2.
Demographic information by treatment condition: PREPP intervention or Enhanced Treatment as Usual (ETAU) (n=60)
| Treatment | |||||||
|---|---|---|---|---|---|---|---|
| Total Sample | PREPP | ETAU | Diff between groups | ||||
| (n=60) | (n=30) | (n=30) | |||||
| Variables | n | Mean (SD) | n | Mean (SD) | n | Mean (SD) | p-valuea |
| or % | or % | or % | |||||
| Demographics | |||||||
| Number of children | 0.55 | ||||||
| = 0 | 23 | 40.40% | 12 | 44.40% | 11 | 36.70% | |
| > 0 | 34 | 59.60% | 15 | 55.60% | 19 | 63.30% | |
| Age | 57 | 28.2 (5.9) | 27 | 27.4 (5.7) | 30 | 28.9 (6.1) | 0.374 |
| Race/Ethnicity | 0.358 | ||||||
| Hispanic / Latina | 48 | 84.20% | 24 | 88.90% | 24 | 80.00% | |
| Not Hispanic / Latina | 9 | 15.80% | 3 | 11.10% | 6 | 20.00% | |
| Baby sex | 0.781 | ||||||
| Male | 25 | 48.10% | 13 | 50.00% | 12 | 46.20% | |
| Female | 27 | 51.90% | 13 | 50.00% | 14 | 53.80% | |
| Baseline symptom scores | |||||||
| EPDS | 54 | 4.8 (3.6) | 27 | 4.5 (3.7) | 27 | 5.2 (3.6) | 0.418 |
| HRSD | 59 | 5.6 (4.5) | 30 | 5 (3.9) | 29 | 6.2 (5) | 0.28 |
| HRSA | 59 | 5.3 (3.8) | 30 | 4.6 (3.7) | 29 | 6.1 (3.9) | 0.134 |
| PHQ-9 | 53 | 4.8 (3.7) | 27 | 4.6 (3.8) | 26 | 5 (3.6) | 0.664 |
| Baseline disorders | |||||||
| EPDS | 1 | ||||||
| >= 9 | 9 | 16.70% | 5 | 18.50% | 4 | 14.80% | |
| HRSD | 0.792 | ||||||
| >= 7 | 23 | 39.00% | 11 | 36.70% | 12 | 41.40% | |
| HRSA | 0.612 | ||||||
| >= 14 | 3 | 5.10% | 1 | 3.30% | 2 | 6.90% | |
| PHQ-9 | 0.669 | ||||||
| >= 10 | 6 | 11.30% | 4 | 14.80% | 2 | 7.70% | |
a
Baseline differences are assessed using Wilcoxon for continuous measures and Fisher’s Exact test for categorical measures